News

Several types of cancer are believed to be linked to alterations of macromolecular structures known as nuclear pore complexes (NPCs). Whether NPC alterations play a role in glioblastoma is unclear at the moment.

A new study from the Massachusetts Institute of Technology has investigated why checkpoint blockade inhibitors - a type of immunotherapy - don't always work as expected.

Electrically charged molecules that trigger self-destruction could be used to target and kill cancer cells in hard-to-treat brain tumors.

Women could be opting to have unnecessary surgery to avoid breast cancer, after being told they are at high risk from genetic test results which do not take family history into account.

Researchers have shown for the first time that breast milk from breast cancer patients contains tumor DNA, known as circulating tumor DNA (ctDNA). This can be detected through liquid biopsy in breast milk.

A study demonstrates that laminin prevents the effects of stiffening, protecting cells against tumor growth. While the mechanism has been demonstrated in vitro, persuasive indications suggest its potential applicability in vivo.

Reflux is a known risk factor for oesophageal cancer, but new research reports that the majority patients don't have a higher cancer risk.

The bones of the spine are derived from a type of stem cell that secretes a metastasis-favoring protein, resulting in tumors frequently spreading to the spine, reports new research.

Metabolites produced by gut bacteria during digestion can be used to trigger an immune response against colorectal cancer cells, according to new research that points toward a potential treatment for one of the deadliest forms of cancer.

A new drug – tulmimetostat – has been given fast-track approval by the US Food and Drug Administration (FDA) to treat some endometrial cancers – a type of uterine cancer.